Recruiting

Postpartum Care in the NICU (PeliCaN) Transitions

This is a randomized controlled trial of a dyad-centered, doula support and healthcare coordination model of care in a large urban neonatal intensive care unit (NICU), which serves a high-risk, low-income, majority Black population. In addition to doula support and coordination of care in the NICU, there will be a warm handoff to a community doula to continue the support once infants leave the Hospital of the University of Pennsylvania (HUP) NICU.

ClinicalTrials.gov IDNCT06521398

PhaseNA

Enrollment20

SponsorUniversity of Pennsylvania

Age16 Years

SexFEMALE

I'm interested View official listing

Conditions studied

Stress Disorders, Post-Traumatic, Premature Birth, Postpartum Depression, Postpartum Anxiety

About this study

Interventions

Other: Doula Support — Doula support including care coordination to mental and medical health services in the NICU, with a warm handoff to a community doula to continue the support once infants leave the HUP NICU.

Primary outcomes

Difference in Post Traumatic Stress Disorder Scores at 6 months postpartum (6 months)
Number of participants who have attendance with a primary care provider by 6 months postpartum (6 months)

Eligibility information

Inclusion Criteria: * HUP postpartum patients who are at least 16 years old at the time their newborns' birth * Infant born at HUP * Preterm birth \<34 weeks * English language speaking Exclusion Criteria: * Unable to read or sign informed consent * Parents of infants transferred into HUP NICU * If the medical team believes that the infant may not live or be transferred to another hospital in upcoming weeks * HUP postpartum patients who are less than 16 years of age at the time of their newborns' birth

Study locations

Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104 United States

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-10-02.